TABLE 10.
Presence of acne in the participants in the two groups, berberine (B) and control (C), at enrolment and after 90 days of treatment.
| Presence of acne | B–baseline (n = 51) | C–baseline | B–90 days | C–90 days |
|---|---|---|---|---|
| Number of subjects, n | 51 | 55 | 51 | 55 |
| Yes, n (%) | 29 (56.9%) | 28 (50.9%) | 13 (25.5%) | 19 (34.5%) |
| Mild, n (%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1 (1.80%) |
| No, n (%) | 22 (43.1%) | 27 (49.1%) | 26 (51.0%) | 30 (54.5%) |
| Improved, n (%) | 0 (0.0%) | 0 (0.0%) | 12 (23.5%) | 5 (9.1%) |
| p between “baseline” values: 0.5389 between “90 days” values: p < 0.05 | ||||
The detailed acne data of all participants are available in Supplementary Material S6. For detailed statistics (Likelihood Ratio, Pearson, and Fisher) see Supplementary Material S7.